Parnax Lab Limited is an India-based holding company. The Company is principally engaged in the business activities of manufacturing and export of pharmaceutical formulations. The Company operates through the trading of the pharmaceuticals and medicinal products segment. It is engaged in developing and delivering huge volumes of oral formulations, such as cough expectorants, antacids, antihistamines, multi-vitamins, enzyme preparations, pediatric formulations, special formulations for geriatrics, viscous products, suspensions, and others. Its product portfolio consists of pharmaceuticals, cosmetics, herbal, and nutraceuticals. Its cosmetics products include antidruf gel, EVE fairness acne care night cream for acne skin, EVE fairness scrub, and others. The Company provides companies with the service of developing the drug through Contract Research and Manufacturing Services (C.R.A.M.S) or manufacturing collaborations. The Company’s subsidiary is Naxpar Pharma Private Limited.As of 14 Jun 2026, PARNAX LAB LTD. share price is ₹130.40. The stock opened at ₹139.00, compared to its previous close of ₹127.30. During today's trading session, PARNAX LAB LTD. share price moved in the range of ₹126.00 to ₹139.00, with an average price of ₹132.50 for the day. Looking at its last 52-week, the stock has touched a low of ₹126.00 and a high of ₹139.00.
The market capitalization of PARNAX LAB LTD. is ₹149 Crs, with a P/E ratio of 12.7 and a dividend yield of 0.00%.